Abstract
Purpose
Hypertriglyceridemia (hyperTG) is common among intensive care unit (ICU) patients, but knowledge about hyperTG risk factors is scarce. The present study aims to identify risk factors favoring its development in patients requiring prolonged ICU treatment.
Methods
Prospective observational study in the medicosurgical ICU of a university teaching hospital. All consecutive patients staying ≥4 days were enrolled. Potential risk factors were recorded: pathology, energy intake, amount and type of nutritional lipids, intake of propofol, glucose intake, laboratory parameters, and drugs. Triglyceride (TG) levels were assessed three times weekly. Statistics was based on two-way analysis of variance (ANOVA) and linear regression with potential risk factors.
Results
Out of 1,301 consecutive admissions, 220 patients were eligible, of whom 99 (45 %) presented hyperTG (triglycerides >2 mmol/L). HyperTG patients were younger, heavier, with more brain injury and multiple trauma. Intake of propofol (mg/kg/h) and lipids’ propofol had the highest correlation with plasma TG (r 2 = 0.28 and 0.26, respectively, both p < 0.001). Infection and inflammation were associated with development of hyperTG [C-reactive protein (CRP), r 2 = 0.19, p = 0.004]. No strong association could be found with nutritional lipids or other risk factors. Outcome was similar in normo- and hyperTG patients.
Conclusions
HyperTG is frequent in the ICU but is not associated with adverse outcome. Propofol and accompanying lipid emulsion are the strongest risk factors. Our results suggest that plasma TG should be monitored at least twice weekly in patients on propofol. The clinical consequences of propofol-related hyperTG should be investigated in further studies.
Similar content being viewed by others
References
Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A (1997) Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 25:33–40
Marik PE (2006) Dyslipidemia in the critically ill. Crit Care Clin 22:151–159 viii
Mantel-Teeuwisse AK, Kloosterman JME, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A (2001) Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf 24:443–456
Maxime V, Annane D (2005) Manifestations endocriniennes liées au sepsis. Réanimation 14:230–237
Bézie Y, Cattan V, Fractal LP, Lescol LP (2003) Comparaison des différentes statines: implications cliniques et choix thérapeutiques. MT Cardio 1:46–54
Crook MA (2000) Lipid clearance and total parenteral nutrition: the importance of monitoring plasma lipids. Nutrition 16:774–775
Shams MR, Tavassoli N, Plicaud H, Genestal M (2009) Incidence and risk factors of hypertriglyceridemia in the ICU. Crit Care Med 13:130
Llop J, Sabin P, Garau M, Burgos R, Perez M, Masso J, Cardona D, Sanchez Segura JM, Garriga R, Redondo S, Sagales M, Ferrer D, Pons M, Vuelta M, Fabregas X, Vitales M, Casasin T, Martinez J, Morato L, Soler M (2003) The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr 22:577–583
Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8:6
Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metabol 89:219–226
Vergès B (2007) Physiopathologie de la dyslipidémie du syndrome métabolique et du diabète de type 2. Nut Clin Metabol 21:9–16
Chien JY, Jerng JS, Yu CJ, Yang PC (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33:1688
Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN (2009) ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 28:387–400
Druml W, Fischer M, Pidlich J, Lenz K (1995) Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr 61:812–817
Tanaka S, Miki T, Hsieh ST, Kim JI, Yasumoto T, Taniguchi T, Ishikawa Y, Yokoyama M (2003) A case of severe hyperlipidemia caused by long-term tube feedings. J Atheroscler Thromb 10:321–324
Theilen HJ, Adam S, Albrecht MD, Ragaller M (2002) Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 95:923–929 (table of contents)
Al Riyami NB, Frohlich J (2008) Extreme hypertriglyceridemia following intravenous heparin infusion. Clin Biochem 41:907–909
Nasstrom B, Olivecrona G, Olivecrona T, Stegmayr BG (2001) Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med 138:206–213
Que YA, Bracco D, Chioléro RL (2007) Aspects métaboliques et nutritionnels des catécholamines et des glucocortioïdesTraité de nutrition artificielle de l’adulte. Springer, Berlin, pp 183–191
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41:159
Calandra T, Cohen J (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538
Berger MM, Revelly JP, Wasserfallen JB, Schmid A, Bouvry S, Cayeux MC, Musset M, Maravic P, Chiolero RL (2006) Impact of a computerized information system on quality of nutritional support in the ICU. Nutrition 22:221–229
Soguel L, Revelly JP, Schaller MD, Longchamp C, Berger MM (2012) Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: The intensive care unit dietitian can make the difference. Crit Care Med 40:412
Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research. Wiley, London
McLeod G, Dick J, Wallis C, Patterson A, Cox C, Colvin J (1997) Propofol 2 % in critically ill patients: effect on lipids. Crit Care Med 25:1976–1981
Baker MT, Naguib M (2005) Propofol: the challenges of formulation. Anesthesiology 103:860–876
Cremer OL (2009) The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder. Crit Care 13:1012
Devlin JW, Mallow-Corbett S, Riker RR (2010) Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 38:S231
Vasile B, Rasulo F, Candiani A, Latronico N (2003) The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29:1417–1425
Devlin JW, Lau AK, Tanios MA (2005) Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy 25:1348–1352
Roth MS, Martin AB, Katz JA (1997) Nutritional implications of prolonged propofol use. Am J Health Syst Pharm (AJHP) 54:694
Petit V, Niot I, Poirier H, Besnard P (2007) Absorption intestinale des acides gras: faits et incertitudes. Nut Clin Metabol 21:38–45
Chambrier C, Lauverjat M, Bouletreau P (2006) Emulsions lipidiques: indication des différentes émulsions lipidiques. Nut Clin Metabol 20:73–78
Nordenstrom J, Carpentier YA, Askanazi J, Robin AP, Elwyn DH, Hensle TW, Kinney JM (1982) Metabolic utilization of intravenous fat emulsion during total parenteral nutrition. Ann Surg 196:221–231
Tappy L, Berger MM, Schwarz JM, Schneiter P, Kim S, Revelly JP, Chiolero R (2006) Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 25:588–595
Chiarla C, Giovannini I, Giuliante F, Zadak Z, Vellone M, Ardito F, Clemente G, Murazio M, Nuzzo G (2010) Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care 25:361.e7–361.e12
Nielsen A, Nielsen R, Riis A, Johnsen S, Sorensen H, Thomsen R (2012) The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study. Crit Care 16:R122
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
J.-C. Devaud and M. M. Berger contributed equally.
Rights and permissions
About this article
Cite this article
Devaud, JC., Berger, M.M., Pannatier, A. et al. Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness. Intensive Care Med 38, 1990–1998 (2012). https://doi.org/10.1007/s00134-012-2688-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-012-2688-8